Investigational Microbiota Restoration Therapeutic for Hepatic Encephalopathy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 07, 2019
Lead Product(s) : Rbx7455
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Rebiotix
Deal Size : Inapplicable
Deal Type : Inapplicable
Treatment of Recurrent Clostridium Difficile Infection With RBX7455
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 05, 2016
Lead Product(s) : Rbx7455
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Rebiotix
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
